Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3337709rdf:typepubmed:Citationlld:pubmed
pubmed-article:3337709lifeskim:mentionsumls-concept:C0010031lld:lifeskim
pubmed-article:3337709lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:3337709lifeskim:mentionsumls-concept:C0072159lld:lifeskim
pubmed-article:3337709pubmed:issue1lld:pubmed
pubmed-article:3337709pubmed:dateCreated1988-2-2lld:pubmed
pubmed-article:3337709pubmed:abstractTextTwo patients with Acanthamoeba keratitis developed a corneal abnormality following prolonged treatment with topical 0.1% [corrected] propamidine isethionate. In both instances, withdrawal of drug therapy resulted in a gradual clearing of the keratopathy, with no permanent sequelae. The changes we observed may be confused with those of active Acanthamoeba infection.lld:pubmed
pubmed-article:3337709pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:languageenglld:pubmed
pubmed-article:3337709pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3337709pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3337709pubmed:statusMEDLINElld:pubmed
pubmed-article:3337709pubmed:monthJanlld:pubmed
pubmed-article:3337709pubmed:issn0003-9950lld:pubmed
pubmed-article:3337709pubmed:authorpubmed-author:O'DayD MDMlld:pubmed
pubmed-article:3337709pubmed:authorpubmed-author:HeadW SWSlld:pubmed
pubmed-article:3337709pubmed:authorpubmed-author:JohnsK JKJlld:pubmed
pubmed-article:3337709pubmed:issnTypePrintlld:pubmed
pubmed-article:3337709pubmed:volume106lld:pubmed
pubmed-article:3337709pubmed:ownerNLMlld:pubmed
pubmed-article:3337709pubmed:authorsCompleteYlld:pubmed
pubmed-article:3337709pubmed:pagination68-9lld:pubmed
pubmed-article:3337709pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:meshHeadingpubmed-meshheading:3337709-...lld:pubmed
pubmed-article:3337709pubmed:year1988lld:pubmed
pubmed-article:3337709pubmed:articleTitleCorneal toxicity of propamidine.lld:pubmed
pubmed-article:3337709pubmed:affiliationDepartment of Ophthalmology, Vanderbilt University Medical Center, Nashville, TN 37232.lld:pubmed
pubmed-article:3337709pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3337709pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3337709pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:3337709pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3337709lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3337709lld:pubmed